Search

Your results

Showing 5 of 5 results

Xenotransplantation, defined as the transplantation of animal derived organs and cells into humans, is currently a very active focus of research as it overrides some of the obstacles encountered with tissue engineering, such as vascularization and innervation. The resurgence of interest in xenotransplantation is mainly attributed to the improvement of gene editing techniques (such as CRISPR/Cas9), since genetically engineered animals have been generated to overcome organ rejection. However, xenotransplantation ...

The Global HIV/AIDS epidemic

At a Glance 30-11-2020

In the middle of the coronavirus pandemic, World Aids Day on 1 December is a timely reminder of the need for continued efforts to tackle other global health problems. Since the first cases were recorded in 1981, the disease has claimed 33 million lives worldwide. New infections and deaths are steadily declining but there are still huge disparities and challenges to meeting the UN target of ending the epidemic by 2030.

World AIDS Day 2019

At a Glance 29-11-2019

Every year, 1 December marks World AIDS Day, proclaimed by the United Nations (UN) in 1988 and aimed mainly at raising awareness. This year's specific theme, 'Communities make a difference', draws attention to the crucial role of community health workers and communities of people living with HIV, highlighting their contribution to ending the epidemic. World AIDS Day also offers an opportunity to take stock of progress, globally and in the EU.

This report summarises the presentations and discussions of a workshop on “Autoimmune Diseases – Modern Diseases”, held at the European Parliament in Brussels on Monday 25 September 2017. The aim of the workshop was to provide background and technical information and advice to the members of the ENVI Committee on the latest findings and trends in the field of autoimmune diseases, specifically concerning treatment and prevention of such diseases. The current state of play of autoimmune diseases in ...

This publication is the result of a project commissioned by STOA under Framework Contract IP/A/STOA/FWC/2005-28 on "Future Development of Cancer Therapy". It contains contributions and discussions arising from a workshop that took place at the European Parliament in Brussels in February 2007 under the title "Gene, Vaccine and Immunotherapies against Cancer: New Approaches to an Old Problem".